Skip to content

A digital health program combined with an activity tracker to improve llifestyle behavior.

Blood glucose regulation in people with diabetes after three months of information about nutrition and feedback on physical activity behavior.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON28551
Enrollment
96
Registered
2015-04-30
Start date
2015-04-24
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HbA1c, diabetes type 2, lifestyle behavior, activity monitoring, feedback. Leefstijl, zelfmeting van beweging, feedback.

Interventions

A digital health program combined with an activity tracker (Fitbit Zip). Participants receive weekly information about physcial activity, nutrition and diabetes. They gain insight in their physical ac

Sponsors

Hanze University of Applied Sciences, research group Healthy ageing, Allied health care and Nursing.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - People with type 2 diabetes - Most recent HbA1c-value ≥ 58 mmols/mol (7.5%) - Age ≥18 jaar - Access to a PC and the internet - some expercience with the use of a computer and the internet.

Exclusion criteria

Exclusion criteria: - Pregnancy - Already exercising more than 3 hours per week - Severe co-morbidity - Cognitive or mental problems

Design outcomes

Primary

MeasureTime frame
HbA1c.

Secondary

MeasureTime frame
Mood (Pick A Mood; PAM) Motivational questionnaire (measured in four determinants: intention, attitude, self-efficacy and social norm) Physcial activity (measured by the Fitbit, and by the 1-item questionnaire) BMI Waist and hip circumference (cm) Compliance use of the digital health program Use of the Fitbit Zip 

Contacts

Public ContactThea Kooiman

Hanzehogeschool Groningen - Wiebengacomplex - HAAL B0.02c t.a.v. Thea Kooiman

t.j.m.kooiman@pl.hanze.nl06-45834078

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)